Skip to main content

Table 2 A comparison of laboratory parameters and treatment between the two groups in MIMIC-IV Database

From: Prognostic value of admission respiratory rate in patients with acute myocardial infarction

 

Total n = 5631

RR ≤ 20 breaths/min n = 3652

RR > 20 breaths/min n = 1979

P value

Laboratory Parameters

 Troponin T (ng/mL)

0.33 (0.1–1.1)

0.34 (0.1–1.05)

0.32 (0.11–1.18)

0.345

 CK-MB (ng/mL)

12.0 (5.0–37.0)

12.0 (5.0–40.0)

11.0 (5.0–35.0)

0.281

 NT-proBNP (pg/mL)

6188.0 (2326.0–16,291.0)

5885.0 (2143.8–15,117.0)

6482.0 (2518.0–17,083.0)

0.166

 Lactate (mmol/L)

1.8 (1.2–2.9)

1.6 (1.2–2.5)

2.2 (1.4–3.7)

< 0.001

 Albumin (g/dL)

3.4 (2.9—3.8)

3.4 (2.9–3.8)

3.3 (2.9–3.7)

0.002

 ALT (u/L)

32.0 (18.0–69.0)

31.0 (19.0–65.5)

33.0 (18.0–75.0)

0.194

 AST (u/L)

55.0 (30.0—139.0)

54.0 (29.0–132.0)

56.0 (31.0–153.0)

0.104

 Total Cholesterol (mg/dL)

161.0 (128.0–194.0)

162.0 (128.0–197.5)

157.0 (127.3–185.8)

0.205

 Triglyceride (mg/dL)

112.0 (81.3–161.8)

110.5 (80.8–161.0)

112.5 (85.0–162.3)

0.345

 HDL-C (mg/dL)

43.0 (35.0–54.0)

43.0 (35.0–53.0)

43.0 (34.0–54.0)

0.687

 LDL-C (mg/dL)

90.0 (62.0–116.0)

91.0 (62.0–117.0)

88.0 (62.0–113.0)

0.405

 Urea (mg/dL)

23.0 (16.0–40.0)

22.0 (15.0–35.0)

27.0 (18.0–46.0)

< 0.001

 Creatinine (mg/dL)

1.2 (0.9–1.8)

1.1 (0.8–1.7)

1.3 (0.9–2.1)

< 0.001

 Uric Acid (mg/dL)

7.8 (5.3–11.4)

7.9 (5.4–12.1)

7.8 (5.2–10.7)

0.374

 Leukocytes (× 109/L)

11.2 (8.3–15.3)

10.9 (8.1–14.6)

11.9 (8.8–16.5)

< 0.001

 Neutrophil (%)

80.7 (72.8–76.6)

79.9 (72.0–85.8)

82.4 (74.0–87.7)

< 0.001

 Hemoglobin (g/L)

11.5 (9.7–13.2)

11.7 (9.9–13.5)

11.1 (9.2–12.8)

< 0.001

 Glucose (mg/dL)

139.0 (110.0–191.0)

134.0 (107.0–182.0)

147.0 (115.0–205.0)

< 0.001

 INR

1.2 (1.1–1.5)

1.2 (1.1–1.5)

1.3 (1.1–1.5)

< 0.001

 PaO2 (mmHg)

106.0 (56.0–289.0)

164.0 (66.0–353.0)

75.0 (47.0–130.0)

< 0.001

 PaCO2 (mmHg)

40.0 (35.0–46.0)

40.0 (36.0–45.0)

40.0 (34.0–47.0)

0.084

Treatments (%)

 Aspirin

5052 (89.7)

3360 (92.0)

1692 (85.5)

< 0.001

 DAPT

2336 (41.5)

1573 (43.1)

763 (38.6)

0.001

 Statins

4889 (86.80

3279 (89.8)

1610 (81.4)

< 0.001

 ACEI

2305 (40.9)

1589 (43.5)

716 (36.2)

< 0.001

 ARB

206 (3.7)

160 (4.4)

46 (2.3)

< 0.001

 Digoxin

249 (4.4)

137 (3.8)

112 (5.7)

< 0.001

 Beta-blockers

4628 (82.2)

3144 (86.1)

1484 (75.0)

< 0.001

 Warfarin

1233 (21.9)

815 (22.3)

418 (21.1)

0.301

Diuretics

 Furosemide

3772 (67.0)

2416 (66.2)

1356 (68.5)

0.072

 Torsemide

434 (7.7)

240 (6.6)

194 (9.8)

< 0.001

 Bumetanide

101 (1.8)

59 (1.6)

42 (2.1)

0.171

Vasopressors and Inotropes

 Dopamine

438 (7.8)

252 (6.9)

186 (9.4)

< 0.001

 Dobutamine

286 (5.1)

149 (4.1)

137 (6.9)

< 0.001

 Epinephrine

584 (10.4)

379 (10.4)

205 (10.4)

0.982

 Norepinephrine

1489 (26.4)

834 (22.8)

655 (33.1)

< 0.001

 Milrinone

257 (4.6)

180 (4.9)

77 (3.9)

0.075

 Morphine

613 (10.9)

335 (9.2)

278 (14.0)

< 0.001

Procedures (%)

 CPR

106 (1.9)

68 (1.9)

38 (1.9)

0.878

 IABP

182 (3.2)

110 (3.0)

72 (3.6)

0.205

 CABG

1281 (22.7)

1096 (30.0)

185 (9.3)

< 0.001

 Ventilator

1276 (22.7)

708 (19.4)

568 (26.7)

< 0.001

 Dilation of Coronary Artery

455 (8.1)

258 (7.1)

197 (10.0)

< 0.001

 ECMO

21 (0.4)

7 (0.2)

14 (0.7)

0.002

  1. ALT Alanine transaminase, AST Aspartate transaminase, CK-MB Creatinine kinase-MB, NT-proBNP N-terminal pro-B-type natriuretic peptide, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, DAPT Dual antiplatelet therapy, ACEI Angiotensin converting enzyme inhibitors, ARB Angiotensin receptor blocker, CPR Cardiopulmonary resuscitation, IABP Intra-aortic balloon pump, CABG Coronary artery bypass grafting, ECMO Extracorporeal membrane oxygenation, INR International normalized ratio, PaO2 arterial partial pressure of oxygen, PaCO2 arterial partial pressure of carbon dioxide